Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Short-term Investments (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) posted Short-term Investments of $566.51 million for Q2 2026, up 71.9% from $329.63 million a year earlier and up 11.8% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Short-term Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Kymera Therapeutics' Short-term Investments came in at $491.27 million, up 33.3% from FY2024.

  • Annual Short-term Investments shows a five-year compound annual growth rate of 13.1% (FY2020 to FY2025).
  • In prior years, Kymera Therapeutics' Short-term Investments was $368.49 million in FY2024 (+39.1%), $264.92 million in FY2023 (-21.8%), $338.77 million in FY2022 (-14.1%) and $394.44 million in FY2021 (+48.7%).
  • The Q2 2026 figure stands as the highest quarterly Short-term Investments in data going back to Q4 2019.
  • On a year-over-year basis, Short-term Investments has increased in each of the last three quarters, with growth averaging 23.8% over the last eight quarters.
  • The strongest year-over-year quarter for Short-term Investments in the past five years was Q2 2026, with growth of 71.9%; the weakest was Q2 2025, with a decline of 25.5%.
  • According to Business Quant data, Short-term Investments for the three prior quarters was $506.84 million (Q1 2026), $491.27 million (Q4 2025) and $392.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kymera Therapeutics 8.89 Bn 6.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 566.51 Mn
Mar 31, 2026 506.84 Mn
Dec 31, 2025 491.27 Mn
Sep 30, 2025 392.73 Mn
Jun 30, 2025 329.63 Mn
Mar 31, 2025 373.18 Mn
Dec 31, 2024 368.49 Mn
Sep 30, 2024 439.25 Mn
Jun 30, 2024 442.34 Mn
Mar 31, 2024 427.03 Mn
Dec 31, 2023 264.92 Mn
Sep 30, 2023 276.77 Mn
Jun 30, 2023 315.19 Mn
Mar 31, 2023 346.73 Mn
Dec 31, 2022 338.77 Mn
Sep 30, 2022 326.25 Mn
Jun 30, 2022 315.40 Mn
Mar 31, 2022 387.08 Mn
Dec 31, 2021 394.44 Mn
Sep 30, 2021 379.57 Mn
API Access

Kymera Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEY